Publications:

Evolution of therapies for chronic myelogenous leukemia.

Cancer Journal (Sudbury, Mass.)

Santos, Fabio P S FP; Kantarjian, Hagop H; Quintás-Cardama, Alfonso A; Cortes, Jorge J

Publication Date: 2011

Variant appearance in text: KIT: Q252R

PubMed Link: 22157290

Variant Present in the following documents:

• Main text

View BVdb publication page

The energy landscape analysis of cancer mutations in protein kinases.

Plos One

Dixit, Anshuman A; Verkhivker, Gennady M GM

Publication Date: 2011

Variant appearance in text: KIT: Q252R

PubMed Link: 21998754

Variant Present in the following documents:

View BVdb publication page

Therapeutic options for chronic myeloid leukemia: focus on imatinib (Glivec, Gleevectrade mark).

Therapeutics And Clinical Risk Management

Henkes, Martin M; van der Kuip, Heiko H; Aulitzky, Walter E WE

Publication Date: 2008-02

Variant appearance in text: KIT: Gln252Arg

PubMed Link: 18728706

Variant Present in the following documents:

• tcrm-0401-163.pdf

View BVdb publication page